IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Flagship Pioneering, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 35 holdings | $2.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Moderna Inc(MRNA)COM60770K107$1.5M12,886,74364.1%
Sana Biotechnology Inc(SANA)COM799566104$205.4K34,239,0188.6%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$148.4K23,117,0456.2%
Omega Therapeutics IncCOM68217N105$140.4K25,902,2695.9%
Foghorn Therapeutics Inc(FHTX)COM344174107$108.7K12,674,1204.6%
Evelo Biosciences IncCOM299734103$105.4K50,427,3284.4%
Denali Therapeutics Inc(DNLI)COM24823R105$80.4K2,619,9683.4%
Axcella Health IncCOM05454B105$32.3K18,867,7851.4%
Rubius Therapeutics IncCOM78116T103$16.6K38,506,5260.7%
Syros Pharmaceuticals Inc(SYRS)COM87184Q206$6.4K993,8480.3%
Sigilon Therapeutics IncCOM82657L107$5.2K10,370,3690.2%
Codiak Biosciences Inc(32W)COM192010106$2.8K3,540,6360.1%